Le Lézard
Classified in: Covid-19 virus
Subject: Stock Sale/Buyback

The First Bancshares, Inc. Announces New Share Repurchase Plan


The First Bancshares, Inc. (NASDAQ: FBMS) ("First Bancshares" or the "Company"), the holding company for The First Bank, announced today that the Company's board of directors has approved a new share repurchase program for the 2022 calendar year.

Under the program, the Company may, but is not required to, from time to time repurchase up to $30 million of shares of its common stock in any manner determined appropriate by the Company's management. The actual timing and method of any purchases, the target number of shares and the maximum price (or range of prices) under the program, will be determined by management at its discretion and will depend on a number of factors, including the market price of the Company's common stock, general market and economic conditions, and applicable legal and regulatory requirements. The new repurchase program replaces the Company's previously-extended 2021 repurchase program, which was completed in February of 2022 when the Company's repurchases under the program approached the maximum authorized amount. The new share repurchase program has an expiration date of December 31, 2022.

About The First Bancshares, Inc.

The First Bancshares, Inc., headquartered in Hattiesburg, Mississippi, is the parent company of The First Bank. Founded in 1996, The First Bank has operations in Mississippi, Louisiana, Alabama, Florida and Georgia. The Company's stock is traded on the NASDAQ Global Market under the symbol FBMS. Additional information is available on the Company's website: www.thefirstbank.com.

Forward-Looking Statements

This release contains "forward-looking statements" within the meaning of and subject to the safe harbor protections of the Private Securities Litigation Reform Act of 1995. In general, forward-looking statements can be identified by the use of words such as "may," "depend," "believe," "expect," "anticipate," "intend," "will," "should," "plan," "estimate," "predict," "continue" and "potential", or the negative of these terms or other comparable terminology. Forward-looking statements represent management's beliefs with regard to the matters addressed, based upon information available at the time the statements are made; they are not guarantees of future performance, and they should they not be relied upon as representing management's views as of any date subsequent to the date first made. Forward-looking statements are subject to numerous assumptions, risks and uncertainties that change over time and could cause actual results or financial condition to differ materially from those expressed in or implied by such statements.

Factors that could affect the forward-looking statements in this release include the Company's ability to continue to generate strong earnings and maintain a strong capital position as it faces the challenge of the ongoing COVID-19 pandemic and other macro-economic factors, public perception and regulatory guidance regarding share repurchase programs, the market price of the Company's common stock, and other opportunities that the Company may determine to pursue. Additional factors affecting forward-looking statements can be found in the cautionary language included under the headings "Management's Discussion and Analysis of Financial Condition and Results of Operations" and "Risk Factors" in the Company's Annual Reports on Form 10-K for the year ended December 31, 2020, and other documents subsequently filed by the Company with the SEC. No forward-looking statement can be guaranteed. The Company expressly disclaims any obligation to update any factors or to announce publicly the result of revisions to any of the forward-looking statements included herein to reflect future events or developments.


These press releases may also interest you

at 00:01
Celltrion USA today announced it will present the two-year results from the extended LIBERTY studies (LIBERTY-CD and LIBERTY-UC) in adult patients...

16 mai 2024
Whitman-Walker Institute, which leverages research, policy, and education to advance health equity nationwide, says it's standing by to further inform the chair of the U.S. House Committee on Education and the Workforce and others about the strong...

16 mai 2024
Amgen today announced that the U.S. Food and Drug Administration (FDA) has approved IMDELLTRAtm (tarlatamab-dlle) for the...

16 mai 2024
Swiss Water Decaffeinated Coffee Inc. ("Swiss Water" or "the Company") is pleased to announce the following voting results of the Company's Annual General Meeting of Shareholders, which was held on Thursday, May 16, 2024. Election of...

16 mai 2024
The global jewelry market in india  size is estimated to grow by USD 21.54 bn from 2023-2027, according to Technavio. The market is estimated to grow at a CAGR of  5.54%  during the forecast period. ...

16 mai 2024
As the world emerges from the devastating impact of the pandemic, the task of rebuilding economies and addressing the financial challenges that have arisen becomes paramount. Despite the passage of time, a significant percentage of Americans, as...



News published on and distributed by: